EP2289872
Læknisfræðileg notkun sértæks andrógenviðtakastillis
Status:
EP Einkaleyfi útrunniðEP appl. date:
7.6.2005EP published:
2.8.2017EP application number:
10075691.5
EP translation filed:
24.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
6.6.2025Expiry date:
6.6.2025
Title:
Medical uses of a selective androgen receptor modulator
Timeline
Today
7.6.2005EP application
2.8.2017EP Publication
24.8.2017Translation submitted
15.9.2017Registration published
6.6.2025Expires
Owner
Name:
University of Tennessee Research FoundationAddress:
211 Conference Center Building, 600 Henley Street, 37996-4122, Knoxville, TN, US
Inventor
Name:
Dalton, James T.Address:
Ann Arbor, MI, US
Name:
Miller, Duane D.Address:
Collierville, TN, US
Name:
Veverka, Karen, A.Address:
Cordova, Tennessee, US
Name:
Kim, JuhyunAddress:
Ellicott City, MD, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
861923Date:
7.6.2004Country:
US
Number:
863524Date:
9.6.2004Country:
US
Number:
961380Date:
12.10.2004Country:
US
Classification
Categories:
A61K 31/17, A61K 31/663, C07C 255/60, C07C 235/24
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 14.5.2018
Expires: 6.6.2019
Payer: Árnason Faktor
Number: 15
Paid: 8.5.2019
Expires: 6.6.2020
Payer: Árnason Faktor
Number: 16
Paid: 2.6.2020
Expires: 6.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 18.5.2021
Expires: 6.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 18
Paid: 18.5.2022
Expires: 6.6.2023
Payer: Patice ehf.
Number: 19
Paid: 24.5.2023
Expires: 6.6.2024
Payer: Árnason Faktor ehf.
Number: 20
Paid: 21.5.2024
Expires: 6.6.2025
Payer: Árnason Faktor ehf.